Jayud Global Logistics Limited announced a new three‑year logistics agreement with Guanghong Electronics, a wholly‑owned subsidiary of DBG Technology Co., Ltd., to provide land and air freight services from China to Hong Kong and to handle full customs processing for Guanghong’s expanding operations in Hong Kong, India and Vietnam.
The contract gives Jayud access to a high‑volume client that serves major consumer‑electronics brands such as Huawei, Xiaomi, Honor and automotive leaders BMW and Volkswagen through DBG’s tier‑1 supplier network. DBG Technology reported 2024 revenue of 6.88 billion RMB (about US$982 million) and has a diversified customer base that includes the brands mentioned above.
For Jayud, the deal is material because the company is currently operating at negative EBITDA of US$4.72 million and a gross margin of 1.95 %. Its Altman Z‑Score of 1.71 places it in the distress zone, so securing a large, recurring revenue stream from a global EMS provider could help stabilize cash flow and improve profitability, even if the incremental margin remains modest.
The agreement also supports DBG Technology’s strategy to expand its supply‑chain footprint in emerging markets. By outsourcing freight and customs clearance to Jayud, Guanghong can focus on manufacturing and product development while ensuring efficient movement of components and finished goods across key growth regions.
"We are excited to partner with Guanghong Electronics and leverage our proprietary IT customs systems to deliver faster, more reliable service for their global supply chain," said Xiaogang Geng, Chairman and CEO of Jayud. Geng added that the partnership would strengthen Jayud’s presence in Shenzhen’s bonded zone network and provide a platform for future growth in cross‑border e‑commerce logistics.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.